Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Wellgistics Health Inc (WGRX)

Wellgistics Health Inc (WGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Wellgistics Health Inc 3000 BAYPORT DRIVE SUITE 950 TAMPA FL 33607 USA

www.wellgisticshealth.com Employees: 31 P: 844-203-6092

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Wellgistics LLC is a pharmaceutical wholesaler distributor, bridging the gap between small to mid-size pharmaceutical manufacturers and independent retail pharmacies. Wellgistics LLC, formerly known as Danam Health Inc., is based in Tampa, FL.

Key Statistics

Overview:

Market Capitalization, $K 36,403
Enterprise Value, $K 58,763
Shares Outstanding, K 89,729
Float, K 49,943
% Float 55.66%
Short Interest, K 695
Short Float 0.77%
Days to Cover 1.57
Short Volume Ratio 0.42
% of Insider Shareholders 44.34%

Financials:

Annual Sales, $ 18,130 K
Annual Net Income, $ -6,860 K
Last Quarter Sales, $ 3,010 K
Last Quarter Net Income, $ -34,320 K
EBIT, $ -69,100 K
EBITDA, $ -67,990 K

Growth:

1-Year Return -89.64%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.44 on 11/19/25
Next Earnings Date 03/24/26
Earnings Per Share ttm -1.17
EPS Growth vs. Prev Qtr -300.00%
EPS Growth vs. Prev Year 244.32%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

WGRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,617.25%
Return-on-Assets % -137.41%
Profit Margin % -37.84%
Debt/Equity 4.25
Price/Sales 1.09
Price/Cash Flow N/A
Price/Book 5.36
Book Value/Share 0.08
Interest Coverage -7.27
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar